194 related articles for article (PubMed ID: 15059947)
1. Thyroid hormone causes mitogen-activated protein kinase-dependent phosphorylation of the nuclear estrogen receptor.
Tang HY; Lin HY; Zhang S; Davis FB; Davis PJ
Endocrinology; 2004 Jul; 145(7):3265-72. PubMed ID: 15059947
[TBL] [Abstract][Full Text] [Related]
2. Thyroid hormone promotes serine phosphorylation of p53 by mitogen-activated protein kinase.
Shih A; Lin HY; Davis FB; Davis PJ
Biochemistry; 2001 Mar; 40(9):2870-8. PubMed ID: 11258898
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk between integrin αvβ3 and estrogen receptor-α is involved in thyroid hormone-induced proliferation in human lung carcinoma cells.
Meng R; Tang HY; Westfall J; London D; Cao JH; Mousa SA; Luidens M; Hercbergs A; Davis FB; Davis PJ; Lin HY
PLoS One; 2011; 6(11):e27547. PubMed ID: 22132110
[TBL] [Abstract][Full Text] [Related]
4. Leptin induces, via ERK1/ERK2 signal, functional activation of estrogen receptor alpha in MCF-7 cells.
Catalano S; Mauro L; Marsico S; Giordano C; Rizza P; Rago V; Montanaro D; Maggiolini M; Panno ML; Andó S
J Biol Chem; 2004 May; 279(19):19908-15. PubMed ID: 14985328
[TBL] [Abstract][Full Text] [Related]
5. Crosstalk between integrin αvβ3 and ERα contributes to thyroid hormone-induced proliferation of ovarian cancer cells.
Hsieh MT; Wang LM; Changou CA; Chin YT; Yang YSH; Lai HY; Lee SY; Yang YN; Whang-Peng J; Liu LF; Lin HY; Mousa SA; Davis PJ
Oncotarget; 2017 Apr; 8(15):24237-24249. PubMed ID: 27458161
[TBL] [Abstract][Full Text] [Related]
6. Acetylation of nuclear hormone receptor superfamily members: thyroid hormone causes acetylation of its own receptor by a mitogen-activated protein kinase-dependent mechanism.
Lin HY; Hopkins R; Cao HJ; Tang HY; Alexander C; Davis FB; Davis PJ
Steroids; 2005; 70(5-7):444-9. PubMed ID: 15862828
[TBL] [Abstract][Full Text] [Related]
7. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
[TBL] [Abstract][Full Text] [Related]
8. Enhanced estrogen receptor (ER) alpha, ERBB2, and MAPK signal transduction pathways operate during the adaptation of MCF-7 cells to long term estrogen deprivation.
Martin LA; Farmer I; Johnston SR; Ali S; Marshall C; Dowsett M
J Biol Chem; 2003 Aug; 278(33):30458-68. PubMed ID: 12775708
[TBL] [Abstract][Full Text] [Related]
9. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
Gilad LA; Bresler T; Gnainsky J; Smirnoff P; Schwartz B
J Endocrinol; 2005 Jun; 185(3):577-92. PubMed ID: 15930183
[TBL] [Abstract][Full Text] [Related]
10. Identification of the putative MAP kinase docking site in the thyroid hormone receptor-beta1 DNA-binding domain: functional consequences of mutations at the docking site.
Lin HY; Zhang S; West BL; Tang HY; Passaretti T; Davis FB; Davis PJ
Biochemistry; 2003 Jun; 42(24):7571-9. PubMed ID: 12809513
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor alpha and beta differentially regulate intracellular Ca(2+) dynamics leading to ERK phosphorylation and estrogen neuroprotection in hippocampal neurons.
Zhao L; Brinton RD
Brain Res; 2007 Oct; 1172():48-59. PubMed ID: 17803971
[TBL] [Abstract][Full Text] [Related]
12. Phospho-serine-118 estrogen receptor-alpha detection in human breast tumors in vivo.
Murphy L; Cherlet T; Adeyinka A; Niu Y; Snell L; Watson P
Clin Cancer Res; 2004 Feb; 10(4):1354-9. PubMed ID: 14977836
[TBL] [Abstract][Full Text] [Related]
13. Interactions between MAP kinase and oestrogen receptor in human breast cancer.
McGlynn LM; Tovey S; Bartlett JM; Doughty J; Cooke TG; Edwards J
Eur J Cancer; 2013 Apr; 49(6):1176-86. PubMed ID: 23265704
[TBL] [Abstract][Full Text] [Related]
14. Estradiol rapidly activates Akt via the ErbB2 signaling pathway.
Stoica GE; Franke TF; Wellstein A; Czubayko F; List HJ; Reiter R; Morgan E; Martin MB; Stoica A
Mol Endocrinol; 2003 May; 17(5):818-30. PubMed ID: 12554767
[TBL] [Abstract][Full Text] [Related]
15. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
Marsaud V; Gougelet A; Maillard S; Renoir JM
Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors alpha and beta in endothelial cells.
Klinge CM; Blankenship KA; Risinger KE; Bhatnagar S; Noisin EL; Sumanasekera WK; Zhao L; Brey DM; Keynton RS
J Biol Chem; 2005 Mar; 280(9):7460-8. PubMed ID: 15615701
[TBL] [Abstract][Full Text] [Related]
17. Thyroxine promotes association of mitogen-activated protein kinase and nuclear thyroid hormone receptor (TR) and causes serine phosphorylation of TR.
Davis PJ; Shih A; Lin HY; Martino LJ; Davis FB
J Biol Chem; 2000 Dec; 275(48):38032-9. PubMed ID: 10982791
[TBL] [Abstract][Full Text] [Related]
18. CSF-1 activates MAPK-dependent and p53-independent pathways to induce growth arrest of hormone-dependent human breast cancer cells.
Lee AW; Nambirajan S; Moffat JG
Oncogene; 1999 Dec; 18(52):7477-94. PubMed ID: 10602507
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor alpha-dependent mechanism: relevance in cell proliferation.
Pozo-Guisado E; Lorenzo-Benayas MJ; Fernández-Salguero PM
Int J Cancer; 2004 Mar; 109(2):167-73. PubMed ID: 14750165
[TBL] [Abstract][Full Text] [Related]
20. Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms.
Manole D; Schildknecht B; Gosnell B; Adams E; Derwahl M
J Clin Endocrinol Metab; 2001 Mar; 86(3):1072-7. PubMed ID: 11238488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
